Thromboelastography Market Business Perspective, Opportunities 2021-2028 | Haemonetics Corporation, Instrumentation Laboratory, Framar Hemologix srl

Thromboelastography (TEG) is used to measure the visco-elastic properties of blood clot formation. It is a major application in surgery and anesthesiology. Increasing use of TEG machines for blood management has helped in predicting and managing bleeding disorders. It also helps in evaluating the risk for re-operation, which leads to cost saving, as it reduces unnecessary blood component transfusions. This machine has applications in hospitals, blood banks, pharmaceutical, and academic institutes.

Rising incidence of surgeries and organ transplant procedures is a major factor that is expected to boost the thromboelastography market growth over the forecast period. For instance, according to U.S. Department of Health and Human Services, 34,770 organ transplants were performed in the U.S in 2017. Rising launch of novel platelet mapping assays and other products is expected to drive the market growth. For instance, in November 2019, Haemonetics Corporation launched the four-channel TEG 6s PlateletMapping ADP & AA assay cartridge. The product is designed for use with TEG 6s Hemostasis Analyzer System.

Request PDF Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2371

Thromboelastography assay is performed to predict the efficiency/strength of the clot during various surgical procedures such as liver transplantation, cardio-pulmonary bypass surgery, and in other applications such as trauma and obstetrics hemorrhage. During the thromboelastography procedure, consumables such as thromboelastography assay reagent, test kits, disposables such as cup and pin, and devices such as TEG systems, analyzer, etc. are required.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it as a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus disease (COVID-19) has resulted in over 9 million infected individuals worldwide as of June 2020.

COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channel, and by its financial impact on firms and financial markets. Due to lockdown, many countries such as Saudi Arabia, UAE, Egypt, and others are facing problems with regards to the transportation of drugs from one place to another.

Furthermore, players operating in the thromboelastography market are facing major challenges on various fronts due to the COVID-19 pandemic. The major challenges include supply of raw materials for manufacturing TEG assay reagents and disposables due to irregularities in transportation facility and distributors who distribute these products in the market are experiencing irregular demand for products from the retailers.

Major players operating in the global thromboelastography market include Haemonetics Corporation, Instrumentation Laboratory, Framar Hemologix srl, Medirox AB, Diagnostica Stago, and Life Diagnostica.

Request Sample Copy of Thromboelastography Report @ https://www.coherentmarketinsights.com/insight/request-sample/2371

Also, Research Report Examines:

• Competitive companies and manufacturers in global market

• By Product Type, Applications & Growth Factors

• Industry Status and Outlook for Major Applications / End Users / Usage Area

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

The post Thromboelastography Market Business Perspective, Opportunities 2021-2028 | Haemonetics Corporation, Instrumentation Laboratory, Framar Hemologix srl appeared first on Gatorledger.

Thromboelastography (TEG) is used to measure the visco-elastic properties of blood clot formation. It is a major application in surgery and anesthesiology. Increasing use of TEG machines for blood management has helped in predicting and managing bleeding disorders. It also helps in evaluating the risk for re-operation, which leads to cost saving, as it reduces unnecessary blood component transfusions. This machine has applications in hospitals, blood banks, pharmaceutical, and academic institutes.

Rising incidence of surgeries and organ transplant procedures is a major factor that is expected to boost the thromboelastography market growth over the forecast period. For instance, according to U.S. Department of Health and Human Services, 34,770 organ transplants were performed in the U.S in 2017. Rising launch of novel platelet mapping assays and other products is expected to drive the market growth. For instance, in November 2019, Haemonetics Corporation launched the four-channel TEG 6s PlateletMapping ADP & AA assay cartridge. The product is designed for use with TEG 6s Hemostasis Analyzer System.

Request PDF Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2371

Thromboelastography assay is performed to predict the efficiency/strength of the clot during various surgical procedures such as liver transplantation, cardio-pulmonary bypass surgery, and in other applications such as trauma and obstetrics hemorrhage. During the thromboelastography procedure, consumables such as thromboelastography assay reagent, test kits, disposables such as cup and pin, and devices such as TEG systems, analyzer, etc. are required.

Since the COVID-19 virus outbreak in December 2019, the disease has spread to over 100 countries across the globe and the World Health Organization has declared it as a public health emergency. According to the World Health Organization’s report, the manifestation of coronavirus disease (COVID-19) has resulted in over 9 million infected individuals worldwide as of June 2020.

COVID-19 can affect the economy in three main ways; by directly affecting production and demand, by creating disruptions in distribution channel, and by its financial impact on firms and financial markets. Due to lockdown, many countries such as Saudi Arabia, UAE, Egypt, and others are facing problems with regards to the transportation of drugs from one place to another.

Furthermore, players operating in the thromboelastography market are facing major challenges on various fronts due to the COVID-19 pandemic. The major challenges include supply of raw materials for manufacturing TEG assay reagents and disposables due to irregularities in transportation facility and distributors who distribute these products in the market are experiencing irregular demand for products from the retailers.

Major players operating in the global thromboelastography market include Haemonetics Corporation, Instrumentation Laboratory, Framar Hemologix srl, Medirox AB, Diagnostica Stago, and Life Diagnostica.

Request Sample Copy of Thromboelastography Report @ https://www.coherentmarketinsights.com/insight/request-sample/2371

Also, Research Report Examines:

• Competitive companies and manufacturers in global market

• By Product Type, Applications & Growth Factors

• Industry Status and Outlook for Major Applications / End Users / Usage Area

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.

The post Thromboelastography Market Business Perspective, Opportunities 2021-2028 | Haemonetics Corporation, Instrumentation Laboratory, Framar Hemologix srl appeared first on Gatorledger.